An Industrial Policy Success Story Trump Should Champion: The Manufacturing Extension Partnership

An Industrial Policy Success Story Trump Should Champion: The Manufacturing Extension Partnership

President Trump has made American reindustrialization and reshoring central to his economic policy agenda. Reviving American manufacturing enjoys broad public support and has increasingly become a bipartisan priority.

CPA Applauds Cassidy, Whitehouse Bill to Close Customs Loophole, Strengthen American Manufacturers

CPA Applauds Cassidy, Whitehouse Bill to Close Customs Loophole, Strengthen American Manufacturers

CPA strongly supports Senator Cassidy and Whitehouse’s Last Sale Valuation Act because it closes a long-standing loophole that has allowed multinational importers to artificially understate the value of goods entering the United States.

CPA: Tax Foundation’s “$1,000 Per Household” Tariff Claim is Economic Malpractice

CPA: Tax Foundation’s “$1,000 Per Household” Tariff Claim is Economic Malpractice

The Tax Foundation’s calculation simply assumes the approximate $132 billion in new 2025 tariff revenue is paid directly by households, dividing that figure across 134.8 million households to produce an average estimate of a $1,000 annual burden per household.

Import Alert: India Drug Maker Recalls Cholesterol Meds Due To Manufacturing Defects

Import Alert: India Drug Maker Recalls Cholesterol Meds Due To Manufacturing Defects

Zydus Pharmaceuticals, one of India’s largest generic drug makers, recalled over 22,000 bottles of a cholesterol medication on Dec. 30, 2025. AvKare, a Tennessee-based pharmaceuticals distribution company that relies on imports, recalled around 7,900 cartons of Rosuvastatin, a widely used generic statin, a day later.

CPA Applauds Clarios, Responsible Battery Coalition Member Company, for Leadership in Sustainable, Secure Battery Supply Chains

CPA Applauds Clarios, Responsible Battery Coalition Member Company, for Leadership in Sustainable, Secure Battery Supply Chains

As highlighted in the Oval Office at the White House this week, Clarios played a part in the launch of ‘Project Vault,’ a major initiative to strengthen U.S. critical minerals security and safeguard American battery supply chains from global disruptions.

Senate Committee: Why Can’t We Label Where Pharmaceuticals Come From?

Senate Committee: Why Can’t We Label Where Pharmaceuticals Come From?

Clothes are labeled. Most food is labeled. Even your car has its manufacturing country of origin stamped onto the door panel. Pharmaceuticals on the other hand, one of the biggest import items and certainly one most critical to our daily health safety and security, usually do not come with any labels at all.